|

ONO-4538 Clinical Trials

2 actively recruiting trials

Also known as: Nivolumab

Pipeline

Phase 2: 2

Top Sponsors

  • Ono Pharmaceutical Co. Ltd2

Indications

  • Cancer2
  • Pan-tumor1
  • Rhabdoid Tumor1

Other2 trials

ONO-4538 Phase II Rollover Study (ONO-4538-98)
Phase 2
Study to ONO-4538 in Patients With Rhabdoid Tumor
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.